Overview
Primer: February 15, 2023
Conference: February 23-24, 2023
DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.
This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for professional development, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory agencies, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.
Participant Testimonials
"Very well-structured meeting. Great information about regulatory processes at FDA, and how we can access the team members there. It is all about building relationships, it is refreshing.” - Catherine Lair - Leadiant Biosciences
“The content was unique, thought provoking, and relevant. Many ad promo presentations are rehashing what we already know. This conference gave me new perspectives to consider.” - Kim Aubrey-Larcinese - CSL Behring
“The event was well organized and relevant to current topics within the industry. Additional speaker/participants from FDA were knowledgeable and enjoyed being able to interact with them in an informal way.” - Suzanne Bayreuther - Sunovion Pharmaceuticals
Keynote Address!
February 23 | 8:00-8:40AM
| Diversity, Equity, and Inclusion in the R&D Space
Jennifer Horonjeff, PhD, CEO, Savvy Cooperative
Featured
Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!
Program Committee
-
Fadwa Almanakly, PharmD Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States -
Sheetal Patel, PharmD Vice President, Specialty Compliance
Johnson & Johnson, United States -
Heather Banuelos, JD Counsel
King & Spalding LLP, United States -
Kimberly Belsky, MS Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States -
Bob Dean, MBA Head of Global Labeling Strategy & Ad/Promo
EMD Serono, United States -
Virginia Foley VP Regulatory, Life Sciences & Healthcare
Constellation, United States -
Catherine Gray, PharmD Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States -
Georgina Lee, PharmD Executive Director, Regulatory Advertising and Promotion
Sage Therapeutics, United States -
Dale Cooke, JD, MA President
Phillycooke Consulting, United States -
Mark Gaydos Former Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States -
Micheline Awad, MBA Sr. Director, Regulatory Advertising, Promotion, and Labeling
Day One Biopharmaceuticals, United States
Have an account?